Recent changes to recommendations for respiratory vaccines have left patients and providers with pressing questions about vaccine access and coverage. Following its most recent meeting in September, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended COVID-19 vaccines for those 6 months and older based on “individual decision-making.” This change in recommendation illuminated the need for stakeholders to have clarity on the impact of ACIP recommendations on respiratory vaccine insurance coverage.
CVEEP hosted a timely discussion on this topic as experts in healthcare coverage, public health, and vaccine policy broke down the relationship between ACIP recommendations and coverage among different types of insurance plans, what to expect at your vaccination appointments this year, and how to advocate for yourself as a patient seeking fall vaccines.
Panelists included:
For pregnant people, maternal vaccines are critical to prenatal care and help protect infants during their first few months of life when newborns are vulnerable to infectious respiratory diseases. As we approach the 2024-2025 respiratory illness season, four vaccines are available to help protect infants, including newly available prevention options. Yet, despite the important role of vaccines during pregnancy, rates of maternal vaccine uptake remain suboptimal.
To further this discussion, Champions for Vaccine Education, Equity and Progress (CVEEP) hosted a conversation on current maternal vaccine guidance, including the maternal RSV vaccine, and potential solutions to address barriers that can impact access to recommended vaccines. The discussion featured provider perspectives across the healthcare continuum and addressed what individuals and organizations can do to help promote maternal vaccination.
Panelists included: